# Aignostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aignostics

- Industry: Software
- Headquarters: Berlin, Germany
- Website: www.aignostics.com/
- Total disclosed funding: $54M
- Latest round: Series B (Oct 15, 2024)
- Investors on record: 10

## About

Aignostics GmbH, located in Berlin, Germany, specializes in the development of advanced AI solutions for precision medicine, focusing on the analysis of biomedical data to enhance drug development and patient outcomes.Founded in 2018, Aignostics GmbH is dedicated to revolutionizing precision medicine through innovative AI technologies. The company operates from its headquarters in Berlin, Germany. Co-founders Klaus Müller, Klauschen Frederick, and Viktor Matyas have combined their expertise in machine learning and biomedical analytics to provide cutting-edge solutions. In its latest funding round, Series B, held on October 15, 2024, Aignostics raised USD 34.00 mn, led by Athos Service and supported by notable investors including Boehringer Ingelheim Venture and Mayo Clinic Ventures. The total amount raised by the company now stands at USD 34.00 mn, with a current valuation of USD 103.16 mn.Aignostics specializes in advanced products and services for precision medicine, focusing on the analysis of complex biomedical data. Their offerings include foundation models that generate embeddings for model training and custom applications for pathology workflows. Key products like the Atlas H&E-TME application enable comprehensive tumor microenvironment profiling using proprietary AI technologies. The company serves a diverse range of clients, including pharmaceutical firms and research institutions, utilizing multimodal datasets from over 30 million pathology samples collected from leading university hospitals and laboratories across Europe and the United States.In 2022, Aignostics reported a revenue of USD 3,098,168.80. The company's revenue model is built around collaborations and contractual agreements with clients in the pharmaceutical and healthcare sectors, focusing on advanced machine learning services for pathology analysis and custom data solutions. Their offerings are likely structured through fees associated with high-value projects, including specialized services for target and biomarker discovery.With the recent Series B funding of USD 34.00 mn, Aignostics plans to accelerate its business expansion and the development of innovative products. The company is set to enhance its existing AI solutions and explore new market opportunities, targeting expansion into North America and Asia by 2025. This growth strategy will leverage the funds raised to support product development and broaden their reach in the precision medicine sector.

## Funding rounds

- Series B, Oct 15, 2024, $34M — Mayo Clinic Ventures, Wellington Partners, IBB Ventures, Boehringer Ingelheim Venture, High-Tech Gruenderfonds, Athos Service, CARMA FUND Management
- Series A, Sep 15, 2022, $14M — Wellington Partners, IBB Ventures, Boehringer Ingelheim Venture, High-Tech Gruenderfonds, CARMA FUND Management
- Seed, Dec 28, 2021 — Boehringer Ingelheim Venture, High-Tech Gruenderfonds, VC Fonds Technologie Berlin, Future Capital
- Seed, Aug 28, 2020, $6M — IBB Ventures, Boehringer Ingelheim Venture, High-Tech Gruenderfonds, Future Capital Discovery Advisory (Hong Kong) Limited

## Investors

- IBB Ventures (https://capitalatlas.ai/funds/ibb-ventures) — Seed, Series A, Series B
- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Seed, Series A, Series B
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed, Series A, Series B
- Future Capital Discovery Advisory (Hong Kong) Limited (https://capitalatlas.ai/funds/future-capital-discovery-advisory-hong-kong-limited) — Seed
- VC Fonds Technologie Berlin — Seed
- Future Capital (https://capitalatlas.ai/funds/future-capital) — Seed
- Wellington Partners (https://capitalatlas.ai/funds/wellington-partners) — Series A, Series B
- CARMA FUND Management (https://capitalatlas.ai/funds/carma-fund-management) — Series A, Series B
- Mayo Clinic Ventures (https://capitalatlas.ai/funds/mayo-clinic-ventures) — Series B
- Athos Service — Series B